Arun Samanta
University of Medicine and Dentistry of New Jersey
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Arun Samanta.
Journal of Parenteral and Enteral Nutrition | 1995
Charles L. Mendenhall; Thomas E. Moritz; Gary A. Roselle; Timothy R. Morgan; Bernard A. Nemchausky; Carlo H. Tamburro; Eugene R. Schiff; Craig J. McClain; Luis Marsano; John I. Allen; Arun Samanta; Robert E. Weesner; William G. Henderson; Thomas S. Chen; Samuel W. French; Antonio Chedid
Background: Active nutrition therapy and the anabolic steroid oxandrolone (OX), in selected patients with severe alcoholic hepatitis, significantly improved liver status and survival. We report here on the changes in their nutritional parameters. Methods: Protein energy malnutrition (PEM) was evaluated and expressed as percent of low normal in 271 patients initially, at 1 month and at 3 months. Active therapy consisted of OX plus a high caloric food supplement vs a matching placebo and a low calorie supplement. Results: PEM was present in every patient; mean PEM score 60% of low normal. Most of the parameters improved significantly from baseline on standard care; the largest improvement seen in visceral proteins, the smallest in fat stores (skinfold thickness). Total PEM score significantly correlated with 6 month mortality (p=.0012). Using logistic regression analysis, creatinine height index, hand grip strength and total peripheral blood lymphocytes were the best risk factors for survival. When CD lymph...
Liver Transplantation | 2005
Baburao Koneru; Adrian Fisher; Yan He; Kenneth M. Klein; Joan Skurnick; Dorian J. Wilson; Andrew N. de la Torre; Anand Merchant; Rakesh K. Arora; Arun Samanta
Ischemic preconditioning (IPC) has the potential to decrease graft injury and morbidity after liver transplantation. We prospectively investigated the safety and efficacy of 5 minutes of IPC induced by hilar clamping in local deceased donor livers randomized 1 : 1 to standard (STD) recovery (N = 28) or IPC (N = 34). Safety was assessed by measurement of heart rate, blood pressure, and visual inspection of abdominal organs during recovery, and efficacy by recipient aminotransferases (aspartate aminotransferase [AST] and alanine aminotransferase [ALT], both measured in U/L), total bilirubin, and international normalized ratio of prothrombin time (INR) after transplantation. IPC performed soon after laparotomy did not cause hemodynamic instability or visceral congestion. Recipient median AST, median ALT, and mean INR, in STD vs. IPC were as follows: day 1 AST 696 vs. 841 U/L; day 3 AST 183 vs. 183 U/L; day 1 ALT 444 vs. 764 U/L; day 3 ALT 421 vs. 463 U/L; day 1 INR 1.7 ± .4 vs. 2.0 ± .8; and day 3 INR 1.3 ± .2 vs. 1.4 ± .3; all P > .05. No instances of nonfunction occurred. The 6‐month graft and patient survival STD vs. IPC were 82 vs. 91% and median hospital stay was 10 vs. 8 days; both P > .05. In conclusion, deceased donor livers tolerated 5 minutes of hilar clamping well, but IPC did not decrease graft injury. Further trials with longer periods of preconditioning such as 10 minutes are needed. (Liver Transpl 2005;11:196–206.)
Gastroenterology | 1993
Antonio Chedid; Charles L. Mendenhall; Thomas E. Moritz; Samuel W. French; Thomas S. Chen; Timothy R. Morgan; Gary A. Roselle; Bernard A. Nemchausky; Carlo H. Tamburro; Eugene R. Schiff; Craig J. McClain; Luis Marsano; John I. Allen; Arun Samanta; Robert E. Weesner; William G. Henderson
BACKGROUND The mechanism responsible for the initiation and perpetuation of alcoholic liver disease (ALD) remains poorly understood. This investigation attempted to elucidate the role of cell-mediated immune phenomena in the pathogenesis of ethanol-induced liver injury. METHODS Frozen liver biopsy specimens from 144 patients with moderate to severe ALD were examined by the avidin-biotin immunoperoxidase technique for the expression of antigenic markers of T and B lymphocytes, natural killer cells, and class I and II MHC molecules in the tissue. RESULTS Expression of CD3 by lymphocytes correlated significantly with regenerating nodules, intralobular inflammation, central sclerosis, and abnormalities of Kupffer cells. B cells were rarely present, and natural killer cells were absent. CD3+ lymphocytes expressed either CD4 or CD8 surface molecules. Enhanced class I MHC expression correlated significantly with portal inflammation, limiting plate erosion, vascular abnormalities, and hemosiderosis. Expression of class II MHC molecules correlated significantly with necrosis, bile stasis, and Mallory bodies. CONCLUSIONS The distribution and persistence of CD4+ and CD8+ cells in actively advancing ALD, the enhanced MHC expression on hepatocytes, and their relationship to alcoholic hyalin and necrosis lend support to the hypothesis that a cytotoxic T lymphocyte-hepatocyte interaction plays a role, perhaps via lymphokine production, in the genesis or perpetuation of ALD.
Transplantation | 2003
Dorian J. Wilson; Adrian C. Fisher; Kasturi Das; Fred Goerlitz; Bart Holland; Andrew N. de la Torre; Anand Merchant; Joseph Seguel; Arun Samanta; Baburao Koneru
Background. Historically, organ recovery rates in donors with cardiac arrest (CA) have been low, presumably from hemodynamic instability. We hypothesized that donor resuscitation has improved hemodynamic stability and organ recovery in CA donors, and that CA triggers ischemic preconditioning (IP) in liver grafts. Methods. A total of 131 donor pairs with and without CA were matched in age, gender, and year of recovery. Hemodynamic stability was determined by vasopressor use. Abdominal and thoracic organs recovered and livers transplanted were compared between the groups. Liver graft function, injury, and IP benefit were examined by comparing liver chemistries after transplantation and postperfusion biopsies between recipients of grafts from both groups (n=40 each). Results. Hemodynamic stability was similar in both groups, but recovery of thoracic organs was significantly lower in CA versus non-CA donors (35 vs. 53%, P <0.01). On the other hand, recovery rates of three or more abdominal organs from CA donors approached those of non-CA donors (77 vs. 87%, not significant). Although significantly fewer livers were transplanted from CA donors (69 vs. 85%, P <0.01), posttransplantation graft function and injury parameters were similar between the two groups, and CA did not appear to trigger IP. Conclusion. Compared with historical data, cardiovascular stability and abdominal organ recovery rates have improved considerably in CA donors. Liver grafts from CA donors function similarly to grafts from non-CA donors with no IP from CA. Our data support the increased use of livers and other organs from donors with CA.
Liver Transplantation | 2004
Hani H. Abujudeh; Arun Samanta; Kyunghee C. Cho; Kenneth M. Klein; Phillip Bahramipour; Baburao Koneru
Portosystemic shunts (PSS) reportedly occur in 18% to19% of patients evaluated for a liver transplant.1,2 In almost all of the patients with large spontaneous PSS, the flow in the portal vein becomes hepatofugal.1 Although smaller PSS do not cause serious problems and will undergo involution over time following transplantation, larger PSS are associated with increased risk of portal vein thrombosis and primary nonfunction from decreased portal flow into the graft.1,2 To prevent complications, ligation of larger PSS is recommended
Hepatology | 2001
Leonard B. Seeff; F. Blaine Hollinger; Harvey J. Alter; Elizabeth C. Wright; Casey M. B. Cain; Zelma J. Buskell; Kamal G. Ishak; Frank L. Iber; Doris Toro; Arun Samanta; Ronald L. Koretz; Robert P. Perrillo
Hepatology | 1993
Charles L. Mendenhall; Thomas E. Moritz; Gary A. Roselle; Timothy R. Morgan; Bernard A. Nemchausky; Carlo H. Tamburro; Eugene R. Schiff; Craig J. McClain; Luis Marsano; John I. Allen; Arun Samanta; Robert E. Weesner; William G. Henderson; Peter S. Gartside; Thomas S. Chen; Samuel W. French; Antonio Chedid
Archives of Surgery | 2004
Lawrence E. Harrison; Trevor W. Reichman; Baburao Koneru; Adrian C. Fisher; Dorian J. Wilson; Andrew N. de la Torre; Arun Samanta; Maria Korogodsky
Gastroenterology | 2010
Bingru Xie; Ravish M. Parekh; Sunita Sood; Kiran V. Rao; Kenneth M. Klein; Baburao Koneru; Adrian C. Fisher; Dorian J. Wilson; Arun Samanta
Gastroenterology | 2011
Richard Arrigo; Arun Samanta; Shanthini Griffith; Ravish M. Parekh; Maria Korogodsky; Kiran V. Rao; Adrian C. Fisher; Dorian J. Wilson; Kenneth M. Klein; Baburao Koneru